TVTX logo

Travere Therapeutics, Inc. (TVTX) Book value

annual book value:

$59.08M-$141.73M(-70.58%)
December 31, 2024

Summary

  • As of today (September 16, 2025), TVTX annual book value is $59.08 million, with the most recent change of -$141.73 million (-70.58%) on December 31, 2024.
  • During the last 3 years, TVTX annual book value has fallen by -$243.03 million (-80.45%).
  • TVTX annual book value is now -81.44% below its all-time high of $318.25 million, reached on December 31, 2018.

Performance

TVTX Book value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXbalance sheet metrics

quarterly book value:

$32.75M-$76.00K(-0.23%)
June 30, 2025

Summary

  • As of today (September 16, 2025), TVTX quarterly book value is $32.75 million, with the most recent change of -$76.00 thousand (-0.23%) on June 30, 2025.
  • Over the past year, TVTX quarterly book value has increased by +$17.60 million (+116.20%).
  • TVTX quarterly book value is now -90.97% below its all-time high of $362.69 million, reached on March 31, 2021.

Performance

TVTX quarterly book value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXbalance sheet metrics

Book value Formula

Book Value = Total Assets − Total Liabilities

TVTX Book value Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-70.6%+116.2%
3 y3 years-80.5%-79.1%
5 y5 years-73.3%-89.7%

TVTX Book value Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-80.5%+37.9%-88.3%+207.5%
5 y5-year-80.5%+37.9%-91.0%+207.5%
alltimeall time-81.4%+258.6%-91.0%+187.9%

TVTX Book value History

DateAnnualQuarterly
Jun 2025
-
$32.75M(-0.2%)
Mar 2025
-
$32.82M(-44.4%)
Dec 2024
$59.08M(-70.6%)
$59.08M(-294.0%)
Sep 2024
-
-$30.45M(-301.1%)
Jun 2024
-
$15.15M(-79.6%)
Mar 2024
-
$74.07M(-63.1%)
Dec 2023
$200.81M(+368.6%)
$200.81M(-28.2%)
Sep 2023
-
$279.77M(+140.2%)
Jun 2023
-
$116.49M(-38.4%)
Mar 2023
-
$189.14M(+341.4%)
Dec 2022
$42.85M(-85.8%)
$42.85M(-57.4%)
Sep 2022
-
$100.68M(-35.8%)
Jun 2022
-
$156.71M(-24.7%)
Mar 2022
-
$208.14M(-31.1%)
Dec 2021
$302.11M(+43.0%)
$302.11M(-1.7%)
Sep 2021
-
$307.37M(-7.5%)
Jun 2021
-
$332.30M(-8.4%)
Mar 2021
-
$362.69M(+71.7%)
Dec 2020
$211.21M(-4.5%)
$211.21M(-29.9%)
Sep 2020
-
$301.41M(-5.4%)
Jun 2020
-
$318.64M(+41.2%)
Mar 2020
-
$225.75M(+2.1%)
Dec 2019
$221.20M(-30.5%)
$221.20M(-10.1%)
Sep 2019
-
$245.96M(-11.2%)
Jun 2019
-
$277.09M(-3.0%)
Mar 2019
-
$285.71M(-10.2%)
Dec 2018
$318.25M(+8.6%)
$318.25M(-0.3%)
Sep 2018
-
$319.07M(+10.8%)
Jun 2018
-
$287.99M(-3.8%)
Mar 2018
-
$299.48M(+2.2%)
Dec 2017
$293.13M
$293.13M(-3.7%)
Sep 2017
-
$304.52M(+2.9%)
Jun 2017
-
$295.83M(-1.7%)
DateAnnualQuarterly
Mar 2017
-
$300.93M(-2.2%)
Dec 2016
$307.77M(+2.6%)
$307.77M(+0.1%)
Sep 2016
-
$307.59M(-2.2%)
Jun 2016
-
$314.37M(-1.5%)
Mar 2016
-
$319.23M(+6.4%)
Dec 2015
$299.97M(-905.3%)
$299.97M(+3.1%)
Sep 2015
-
$291.01M(+93.0%)
Jun 2015
-
$150.78M(-10.6%)
Mar 2015
-
$168.57M(-552.5%)
Dec 2014
-$37.25M(+89.4%)
-$37.25M(+265.6%)
Sep 2014
-
-$10.19M(-1055.0%)
Jun 2014
-
$1.07M(-103.0%)
Mar 2014
-
-$35.39M(+80.0%)
Dec 2013
-$19.67M(+477.1%)
-$19.67M(+238.8%)
Sep 2013
-
-$5.80M(-31.4%)
Jun 2013
-
-$8.46M(+162.5%)
Mar 2013
-
-$3.22M(-5.5%)
Dec 2012
-$3.41M(+5551.4%)
-$3.41M(+5414.2%)
Nov 2011
-
-$61.80K(+0.8%)
Aug 2011
-
-$61.30K(+0.8%)
May 2011
-
-$60.80K(+0.8%)
Feb 2011
-$60.30K(+22.6%)
-$60.30K(+1.9%)
Nov 2010
-
-$59.20K(+4.8%)
Aug 2010
-
-$56.50K(+6.8%)
May 2010
-
-$52.90K(+7.5%)
Feb 2010
-$49.20K(+47.7%)
-$49.20K(+8.8%)
Nov 2009
-
-$45.20K(+8.7%)
Aug 2009
-
-$41.60K(+9.8%)
May 2009
-
-$37.90K(+13.8%)
Feb 2009
-$33.30K(-36.0%)
-$33.30K(+16.0%)
Nov 2008
-
-$28.70K(-45.2%)
Aug 2008
-
-$52.40K(0.0%)
May 2008
-
-$52.40K
Feb 2008
-$52.00K
-

FAQ

  • What is Travere Therapeutics, Inc. annual book value?
  • What is the all time high annual book value for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. annual book value year-on-year change?
  • What is Travere Therapeutics, Inc. quarterly book value?
  • What is the all time high quarterly book value for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. quarterly book value year-on-year change?

What is Travere Therapeutics, Inc. annual book value?

The current annual book value of TVTX is $59.08M

What is the all time high annual book value for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high annual book value is $318.25M

What is Travere Therapeutics, Inc. annual book value year-on-year change?

Over the past year, TVTX annual book value has changed by -$141.73M (-70.58%)

What is Travere Therapeutics, Inc. quarterly book value?

The current quarterly book value of TVTX is $32.75M

What is the all time high quarterly book value for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high quarterly book value is $362.69M

What is Travere Therapeutics, Inc. quarterly book value year-on-year change?

Over the past year, TVTX quarterly book value has changed by +$17.60M (+116.20%)
On this page